On November 15, 2019, in connection with Mr. Imbrogno's June 20, 2019 appointment as Vice President, Finance and Chief Accounting Officer of PDL BioPharma, Inc., the Compensation Committee of the Board of Directors of PDL BioPharma, Inc. Also on November 15, 2019, the Board appointed Edward A. Imbrogno as the Company's Acting Chief Financial Officer while the Company continues its search for a permanent chief financial officer. During this time, Mr. Imbrogno will continue his duties as the Company's Vice President, Finance and Chief Accounting Officer and will receive no compensation for his additional service to the Company.